SS Innovations International (NASDAQ:SSII) Lowered to Sell Rating by Wall Street Zen

SS Innovations International (NASDAQ:SSIIGet Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Several other research analysts have also weighed in on the stock. Loop Capital set a $7.00 price objective on shares of SS Innovations International in a research note on Wednesday, June 3rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of SS Innovations International in a research note on Tuesday, April 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, SS Innovations International currently has a consensus rating of “Sell” and an average target price of $7.00.

Get Our Latest Research Report on SSII

SS Innovations International Stock Performance

NASDAQ:SSII opened at $3.47 on Friday. The stock has a market capitalization of $694.45 million, a PE ratio of -69.40 and a beta of -1.88. SS Innovations International has a 1-year low of $3.11 and a 1-year high of $11.87. The firm has a fifty day simple moving average of $4.05 and a 200 day simple moving average of $4.71.

SS Innovations International (NASDAQ:SSIIGet Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $11.10 million for the quarter. SS Innovations International had a negative return on equity of 23.00% and a negative net margin of 20.69%.

Institutional Investors Weigh In On SS Innovations International

Large investors have recently added to or reduced their stakes in the business. Handelsbanken Fonder AB lifted its holdings in SS Innovations International by 9.3% during the 4th quarter. Handelsbanken Fonder AB now owns 120,000 shares of the company’s stock valued at $682,000 after purchasing an additional 10,198 shares during the last quarter. Eversept Partners LP increased its holdings in shares of SS Innovations International by 46.2% in the first quarter. Eversept Partners LP now owns 110,157 shares of the company’s stock valued at $551,000 after purchasing an additional 34,799 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of SS Innovations International by 26.4% in the first quarter. Inspire Investing LLC now owns 104,624 shares of the company’s stock valued at $523,000 after purchasing an additional 21,851 shares during the last quarter. JNBA Financial Advisors bought a new position in shares of SS Innovations International in the fourth quarter valued at about $498,000. Finally, AlphaCentric Advisors LLC bought a new position in shares of SS Innovations International in the fourth quarter valued at about $284,000.

SS Innovations International Company Profile

(Get Free Report)

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.

Further Reading

Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.